Moy B, Oliveira M, Saura C, Gradishar W, et al. Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and >/= 2 prior HER2-directed regimens. Breast Cancer Res Treat 2021 Apr 28. pii: 10.1007/s10549-021-06217.
PMID: 33909203